Angiotensin-converting enzyme and enkephalinase in human breast cyst fluid
1996

Enzymes in Breast Cyst Fluid and Their Link to Cancer Risk

Sample size: 57 publication Evidence: moderate

Author Information

Author(s): KL Frame, K Patton, MJ Reed, MW Ghilchik, DC Parish

Primary Institution: St Mary's Hospital Medical School, Imperial College of Science, Technology & Medicine

Hypothesis

Higher levels of peptidases in breast cyst fluid may reflect a protective environment against breast cancer.

Conclusion

The study found that angiotensin-converting enzyme levels are significantly higher in type 2 breast cyst fluid compared to type 1, suggesting a potential protective role.

Supporting Evidence

  • Type 2 breast cyst fluid had significantly higher ACE levels than type 1.
  • ACE activity was inversely correlated with serum ACE levels.
  • Peptidases in breast cyst fluid may modulate the growth of carcinomas.

Takeaway

This study looked at fluids from breast cysts to see if certain enzymes could help protect against breast cancer. They found that one enzyme was higher in a type of cyst that is less likely to lead to cancer.

Methodology

Breast cyst fluid was obtained by needle aspiration and analyzed for enzyme activity using various assays.

Limitations

The study did not determine the exact origin of the peptidases in breast cyst fluid.

Participant Demographics

Women attending the breast clinic at St Mary's Hospital, London.

Statistical Information

P-Value

0.001

Statistical Significance

p<0.001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication